humburger icon

MASCC Webinar: CDK 4/6 Inhibitors: Personalizing Treatment Choices and Optimizing Multidisciplinary Care

Home > News > MASCC Webinar: CDK 4/6 Inhibitors: Personalizing Treatment Choices and Optimizing Multidisciplinary Care
A person looking at a webinar on a tablet screen. Text at the bottom reads "Webinar"

MASCC Webinar: CDK 4/6 Inhibitors: Personalizing Treatment Choices and Optimizing Multidisciplinary Care

March 1, 2023
5:00 PM – 6:00 PM CET
11:00 AM – 12:00 PM EST
8:00 AM – 9:00 AM PST

Objectives:

  • To improve the understanding of clinicians in identifying which CDK 4/6 treatment to choose in taking a shared decision approach
  • The patient experience of targeted therapy toxicities and how it impacts quality of life, adherence, and disease outcomes
  • Identify innovative strategies to optimally manage related toxicities with CDK4/6 inhibitors in patients with breast cancer

Learner Outcomes:

  • How to make personalized treatment decisions for patients with hormone receptor positive breast cancer who are candidates for CDK 4/6 inhibitors
  • How to improve supportive care strategies for patients with breast cancer who are undergoing targeted therapy
  • Address in knowledge in management and how to best deliver multi D care for cancer survivors of all stages

Speakers:

  • Prof Maryam Lustberg (Session Chair)
  • Prof Hope Rugo
  • Dr Kelly Shanahan (Patient Advocate)
  • Dr Paolo Tarantino

This webinar was made possible by an unrestricted educational grant provided by Pfizer

  • All
  • Affiliates & Partners
  • Announcements
  • Annual Meeting
  • Centers of Excellence
  • Research Highlights